5AM Ventures
A senior leader in analytical chemistry or pharmaceutical sciences responsible for developing and validating robust bioanalytical methods for PK/PD and biomarker studies. This role involves overseeing CRO-managed programs, ensuring GLP compliance, and providing expert interpretation of complex data for IND-enabling and clinical trials.
Headquarters
San Francisco, California, United States
Company Size
11-50 employees
Founded
2002
5AM Ventures is an early-stage venture capital firm that partners with scientists and entrepreneurs to create and scale transformative life-science companies. They focus on seed and Series A investments across therapeutics, diagnostics, medical devices, and research tools, combining capital with hands-on operational support, strategic guidance, and board-level engagement. Known for a company-creation mindset, 5AM helps translate novel science into scalable businesses aimed at improving patient care and enabling breakthrough technologies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for 5AM Ventures.
5AM Ventures didn’t post a salary, so this is our estimate from similar listings.
Scientist/Senior Scientist
ASTARPRD
Principal Scientist, Translational Bioanalysis and Biomarkers
Nucleome
Associate Director, Bioanalytical Sciences & Biomarkers
Arbor Biotechnologies
Scientist III
WuXi AppTec
Biomarker & Bioanalytical Development Lead
Borealisbio
Senior Scientist, Translational Science
Spyre Therapeutics